Antibacterial agent 337
Antibacterial agent 337 is an antibacterial agent. Antibacterial agent 337 specifically interacts with PG in bacterial cell membranes, triggering membrane disruption, membrane depolarization, increased permeability, cytoplasmic leakage, ROS accumulation and rapid bacterial death. Antibacterial agent 337 inhibits biofilm formation and disrupts mature biofilms. Antibacterial agent 337 exhibits potent in vivo antibacterial efficacy in a mouse model of Staphylococcus aureus skin abscess. Antibacterial agent 337 can be used in studies of Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus infections, vancomycin-resistant Enterococcus faecalis infections and bacterial biofilm infections.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C78H92Br2N2O4P2
- 分子量:1343.33
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
Antibacterial agent 337 (Compound 10 b) (0-64 μg/mL; 8 h for S. aureus, 2 h for HEK293T) selectively neutralizes the anionic surface charge of S. aureus ATCC25923 in a concentration-dependent manner, while exerts no effect on the zeta potential of HEK293T mammalian cells[1].
Antibacterial agent 337 (0-128 μg/mL, 24 h) exhibits potent antibacterial activity against Gram-positive bacteria (S. aureus 25923, S. aureus 43300, E. faecalis 29212, E. faecalis 51299, B. subtilis 9372) with an MIC of 1-4 μg/mL, while shows weak activity against Gram-negative bacteria[1].
Antibacterial agent 337 inhibits biofilm formation of S. aureus ATCC25923, binds specifically to phosphatidylglycerol (PG), and significantly increases ROS[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (male, 6-8 weeks old)[1]
-
Dosage:5 mg/kg; 10 mg/kg
-
Administration:s.c.; single dose
-
Result:Reduced the bacterial load by 1.28 log10 CFU/g (93.38% decrease in bacterial survival) at 5 mg/kg.
Reduced the bacterial load by 2.99 log10 CFU/g (99.89% decrease in bacterial survival) at 10 mg/kg.
Significantly reduced pustule formation and inflammatory infiltration at 5 mg/kg.
Eliminated obvious inflammatory cells in epidermal and dermal layers, with tissue architecture resembling uninfected controls at 10 mg/kg.
化学情報
-
分子量 1343.33
-
分子式 C78H92Br2N2O4P2
-
SMILES
C=CCC1=CC=C(OCC(N(CCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)CCCCCC)=O)C(C5=CC=C(OCC(N(CCCC[P+](C6=CC=CC=C6)(C7=CC=CC=C7)C8=CC=CC=C8)CCCCCC)=O)C(CC=C)=C5)=C1.[Br-].[Br-]
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Antibacterial agent 337 関連分類
HY-182798 関連分類
Powered by Bioz
- Antibacterial agent 337
- Antibacterial agent337
- Antibacterial agent-337
- Bacterial
- Reactive Oxygen Species (ROS)
- methicillin-resistant staphylococcus aureus infection
- gram-positive bacterial infections
- S. aureus ATCC25923
- bacterial membranes
- reactive oxygen species
- HEK293T mammalian cells
- bacterial biofilm infections
- anionic phosphatidylglycerol
- murine S. aureus skin abscess model
- vancomycin-resistant enterococcus faecalis infection
- Inhibitor
- inhibitor
- inhibit